Targeting 3-phosphoinositide-dependent protein kinase 1 associated with drug-resistant renal cell carcinoma using new oridonin analogs
Jiancheng Zhou(Shanxi Medical University), Jer‐Tsong Hsieh(The University of Texas Southwestern Medical Center)
Cited by 28